Patient experiences and motivations in tuberculosis treatment: Insights from a digital adherence technology trial. | ClinicLens
Non-adherence to Tuberculosis (TB) treatment remains a global health challenge, particularly in low- and middle-income countries. Digital Adherence Technologies (DATs) have shown promise in improving treatment outcomes, yet little is known about user perceptions. Through an exit
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.